Cystic Fibrosis Gene Mutation Frequency Among a Group of Suspected Children in King Hussein Medical Center.
Autor: | Al-Abadi B; Immunology Department, Prince Iman Center, Amman, Jordan., Al-Hiary M; Immunology Department, Prince Iman Center, Amman, Jordan., Khasawneh R; Hematology Department, Prince Iman Center, Amman, Jordan., Al-Momani A; Hematology Department, Prince Iman Center, Amman, Jordan., Bani-Salameh A; Internal Medicine, King Hussein Medical Center, Amman, Jordan., Al-Saeidat S; Hematology Department, Prince Iman Center, Amman, Jordan., Al-Khlaifat A; Pediatric Department, King Hussein Medical Center, Amman, Jordan., Aboalsondos O; Immunology Department, Prince Iman Center, Amman, Jordan. |
---|---|
Jazyk: | angličtina |
Zdroj: | Medical archives (Sarajevo, Bosnia and Herzegovina) [Med Arch] 2019 Apr; Vol. 73 (2), pp. 118-120. |
DOI: | 10.5455/medarh.2019.73.118-120 |
Abstrakt: | Introduction: Cystic fibrosis (CF) is a genetic multisystem disorder that affects mostly the lungs, but other organs such as liver, pancreas and intestine also affected. CF is inherited in an autosomal recessive manner and occurs in males and females equally. Cystic fibrosis Transmembrane Conductance Regulator (CFTR) mutations are classified into five classes. Class 1 (non-functional protein), class 2 (near-absence of mature CFTR protein at the apical cell membrane), class 3 (full-length CFTR protein incorporated into the cell membrane), class 4 (reduced conductance CFTR mutation), and class 5 (reduced amount of CFTR protein with normal function). Globally F508 mutation is the most common. Aim: The aim of this study was to determine the frequency of CFTR gene mutation in Jordanian populations attending a major hospital (KHMC). Material and Methods: This is a retrospective study was conducted on 777 sera samples for patients clinically suspected to have cystic fibrosis over a six year period 1/1/2013-1/10/2018. The patient's age range between 1year and 33 years, of which 59.2% (460) were male and 40.8% (317) female. Blood samples were analyzed at Princess Iman Centre for Research and Laboratory Sciences at King Hussein Medical Centre. The samples were tested for 34 mutations of CFTR gene using CF Strip Assay VIENNA LAB Diagnostics GmbH, Austria by polymerase chain reaction (PCR). Results: A total of 777 patients samples were analyzed for cystic gene mutations. Twelve (12) mutations were identified. In 49 patients (6.3%) were heterozygous genotype mutant and 28 (3.6%) were homozygous. The most frequent mutation F508del was found in 32/77 (41.5%). 20 (25.9%) of them were heterozygous genotype mutant and 12 (15.6%) were homozygous genotype mutant. The second frequent mutation was N1303K with frequency rate 15.6% (12/77), 9 (11.7%) of them were heterozygous and 3 (3.9%) were homozygous. Regarding frequency of cystic fibrosis gene mutation depending on sex, 55.8% (43/77) of mutations were found in male, whereas 44.2% (34/77) in female. Conclusion: Our findings suggest that cystic fibrosis in Jordan is not a rare disease, and found that the most frequent CFTR gene mutation was F508del, which is in keeping with results from other Mediterranean countries. |
Databáze: | MEDLINE |
Externí odkaz: |